Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Alliance on Test for Congestive Heart Failure

By HospiMedica staff writers
Posted on 21 Dec 2000
The National Research Council of Canada (NRC) has agreed to support the development of a diagnostic test for congestive heart failure (CHF) by Syn X Pharma Inc. More...
(Toronto, Canada).

The agreement will provide Syn X with funding to undertake the research and development of unique, stage-specific heart failure proteins. These will be used to create simple, rapid blood tests to diagnose heart failure in its earliest stages. Currently, there is no test to identify early-stage heart failure in asymptomatic patients, says Syn X. The company has isolated a number of blood markers associated with heart failure and expects to develop a blood test for regulatory review in 2001. NRC support will also allow Syn X to develop a test for the early identification of CHF, when medical intervention can still save lives. Some of the funding will also be devoted to identifying previously unknown blood markers to add to Syn X's diagnostic pipeline.

Syn X has also developed a test to diagnose stroke (Strokepanel). The company capitalizes on its Proteomics Discovery Platform to discover novel drug targets and develop diagnostic tests.



Related Links:
Syn X

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.